InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.54
(
0.00%
)
US TECH 100
19,045.60
(
-0.84%
)
Dow Jones
39,428.44
(
0.71%
)
Brent Oil
85.27
(
1.49%
)
Bitcoin
60,062.67
(
-4.90%
)
Post# of 252331
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: acgood post# 93234

Friday, 03/26/2010 3:19:05 PM

Friday, March 26, 2010 3:19:05 PM

Post# of 252331

Not to mention it [Zevalin] works better and is recommended over rituxan.

I've noticed that there are many ongoing clinical trials testing Zevalin in varying combinations and indications. I didn't see any head to head against Rituxan in 1st line like this study testing CHOP+Bexxar vs. CHOP+Rituxan in 1st line follicular NHL:

http://clinicaltrials.gov/ct2/show/NCT00006721

Seems to me that this kind of study might boost the use of these radio-labeled antibodies. Has SPPI talked about such study with Zevalin?


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up